A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada. Canadian Cardiovascular Society

Can J Cardiol. 1997 Jan;13(1):33-45.
[Article in English, French]
No abstract available

Publication types

  • Guideline

MeSH terms

  • Canada
  • Cardiology
  • Cardiovascular Agents / economics*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / economics
  • Cost Control
  • Drug Costs
  • Humans
  • Prescription Fees / standards*
  • Quality of Health Care
  • Rate Setting and Review
  • Research
  • Societies, Medical

Substances

  • Cardiovascular Agents